ALBIERO, MATTIA
 Distribuzione geografica
Continente #
NA - Nord America 8.014
AS - Asia 3.054
EU - Europa 2.047
AF - Africa 804
SA - Sud America 593
OC - Oceania 91
Continente sconosciuto - Info sul continente non disponibili 41
Totale 14.644
Nazione #
US - Stati Uniti d'America 7.619
SG - Singapore 1.089
CN - Cina 689
IT - Italia 459
HK - Hong Kong 373
BR - Brasile 348
DE - Germania 249
VN - Vietnam 188
FI - Finlandia 176
SE - Svezia 148
GB - Regno Unito 129
PL - Polonia 83
FR - Francia 77
NL - Olanda 69
RU - Federazione Russa 63
BJ - Benin 55
IN - India 50
UA - Ucraina 50
CI - Costa d'Avorio 46
AR - Argentina 44
ZA - Sudafrica 42
MX - Messico 39
EC - Ecuador 34
CA - Canada 32
TR - Turchia 32
IE - Irlanda 30
IL - Israele 30
JM - Giamaica 30
JP - Giappone 30
AO - Angola 29
AT - Austria 29
PA - Panama 29
ES - Italia 28
IQ - Iraq 28
VE - Venezuela 28
EG - Egitto 27
MY - Malesia 27
PY - Paraguay 27
CH - Svizzera 26
CO - Colombia 26
EE - Estonia 26
NZ - Nuova Zelanda 26
UG - Uganda 26
CG - Congo 25
ID - Indonesia 25
KZ - Kazakistan 25
MR - Mauritania 25
NI - Nicaragua 25
AE - Emirati Arabi Uniti 23
AZ - Azerbaigian 23
GR - Grecia 23
IR - Iran 23
MA - Marocco 23
MZ - Mozambico 23
PE - Perù 23
PT - Portogallo 23
SA - Arabia Saudita 23
TN - Tunisia 23
BA - Bosnia-Erzegovina 22
CV - Capo Verde 22
DK - Danimarca 22
DZ - Algeria 22
LV - Lettonia 22
PS - Palestinian Territory 22
AL - Albania 21
BE - Belgio 21
CY - Cipro 21
GF - Guiana Francese 21
TH - Thailandia 21
CD - Congo 20
CR - Costa Rica 20
GT - Guatemala 20
JO - Giordania 20
LA - Repubblica Popolare Democratica del Laos 20
PH - Filippine 20
RO - Romania 20
TW - Taiwan 20
BZ - Belize 19
LU - Lussemburgo 19
LY - Libia 19
ML - Mali 19
PR - Porto Rico 19
UY - Uruguay 19
XK - ???statistics.table.value.countryCode.XK??? 19
AM - Armenia 18
CW - ???statistics.table.value.countryCode.CW??? 18
CZ - Repubblica Ceca 18
DJ - Gibuti 18
GA - Gabon 18
HN - Honduras 18
KE - Kenya 18
NC - Nuova Caledonia 18
RW - Ruanda 18
TZ - Tanzania 18
ZW - Zimbabwe 18
BY - Bielorussia 17
GH - Ghana 17
GN - Guinea 17
HT - Haiti 17
KH - Cambogia 17
Totale 13.853
Città #
Fairfield 1.131
Ashburn 806
Woodbridge 676
Ann Arbor 646
Singapore 595
Chandler 536
Houston 523
Seattle 423
Cambridge 416
Wilmington 376
Hong Kong 347
Beijing 212
Boardman 133
Santa Clara 118
San Diego 111
Padova 106
Jacksonville 99
Princeton 98
Los Angeles 90
Helsinki 77
New York 73
Munich 65
Medford 64
Roxbury 63
Dong Ket 55
Nanjing 53
Cotonou 52
Des Moines 51
Guangzhou 50
Ho Chi Minh City 48
Bytom 47
Abidjan 45
London 37
São Paulo 36
Turku 36
Frankfurt am Main 34
Milan 33
Buffalo 32
Chicago 32
Hanoi 30
Rome 30
Panama City 27
Shanghai 27
Kampala 26
Dearborn 25
Managua 24
Nouakchott 24
Warsaw 24
Baku 23
Tallinn 23
Hefei 22
Luanda 22
Jinan 21
Tokyo 20
Boston 19
Brooklyn 19
Johannesburg 19
Maputo 19
Vienna 19
Amman 18
Kigali 18
Montevideo 18
Nanchang 18
Shenyang 18
Bamako 17
Conakry 17
Dublin 17
Kinshasa 17
Libreville 17
Praia 17
Redondo Beach 17
Vientiane 17
Yerevan 17
Dili 16
Djibouti 16
Kingston 16
Nairobi 16
Riga 16
San José 16
Cayenne 15
Lilongwe 15
Nassau 15
Niamey 15
Noumea 15
Nuremberg 15
Phnom Penh 15
Phoenix 15
Rio de Janeiro 15
Tashkent 15
Ulan Bator 15
Willemstad 15
Accra 14
Brazzaville 14
Bridgetown 14
Cairo 14
Castries 14
Dallas 14
Harare 14
Lima 14
Changsha 13
Totale 9.532
Nome #
Age-Associated Loss of OPA1 in Muscle Impacts Muscle Mass, Metabolic Homeostasis, Systemic Inflammation, and Epithelial Senescence 514
miR-30c-5p regulates macrophage-mediated inflammation and pro-atherosclerosis pathways 265
NETosis delays diabetic wound healing in mice and humans 259
Bone marrow macrophages contribute to diabetic stem cell mobilopathy by producing Oncostatin M. 256
DRP1-mediated mitochondrial shape controls calcium homeostasis and muscle mass 243
Endothelial progenitor cells are reduced in acromegalic patients and can be restored by treatment with somatostatin analogs. 241
Diabetes-associated myelopoiesis drives stem cell mobilopathy through an OSM-p66Shc signaling pathway 238
NETosis is induced by high glucose and associated with type 2 diabetes. 229
A perspective on NETosis in diabetes and cardiometabolic disorders 221
Mitochondrial Calcium Uptake Is Instrumental to Alternative Macrophage Polarization and Phagocytic Activity 214
p66Shc deletion or deficiency protects from obesity but not metabolic dysfunction in mice and humans 213
Acute effects of linagliptin on progenitor cells, monocyte phenotypes, and soluble mediators in type 2 diabetes 207
Diabetes Limits Stem Cell Mobilization Following G-CSF but not Plerixafor. 201
The antidiabetic drug metformin blunts NETosis in vitro and reduces circulating NETosis biomarkers in vivo 197
Non-genomic mechanisms in the estrogen regulation of glycolytic protein levels in endothelial cells 196
Circulating myeloid calcifying cells have anti-angiogenic activity via thrombospondin-1 overexpression 196
Circulating Progenitor Cell Count Predicts Microvascular Outcomes in Type 2 Diabetic Patients 191
Interplay between gut microbiota and p66Shc affects obesity-associated insulin resistance 189
An unbalanced monocyte polarisation in peripheral blood and bone marrow of patients with type 2 diabetes has an impact on microangiopathy. 189
Short-term statin discontinuation increases endothelial progenitor cells without inflammatory rebound in type 2 diabetic patients. 188
Endothelial properties of third-trimester amniotic fluid stem cells cultured in hypoxia 186
Arrhythmogenic Cardiomyopathy Is a Multicellular Disease Affecting Cardiac and Bone Marrow Mesenchymal Stromal Cells 185
Procalcific phenotypic drift of circulating progenitor cells in type 2 diabetes with coronary artery disease. 184
Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats. 180
Generation and validation of novel adeno-associated viral vectors for the analysis of Ca2+ homeostasis in motor neurons 180
Diabetes causes bone marrow autonomic neuropathy and impairs stem cell mobilization via dysregulated p66Shc and Sirt1 178
Endothelial progenitor cells as resident accessory cells for post-ischemic angiogenesis. 176
The peritoneum as a natural scaffold for vascular regeneration. 175
Hematopoietic and Nonhematopoietic p66Shc Differentially Regulates Stem Cell Traffic and Vascular Response to Ischemia in Diabetes 175
Inhibition of SGLT-2 rescues bone marrow cell traffic for vascular repair. Role of glucose control and ketogenesis 170
Diabetes Impairs Stem Cell and Proangiogenic Cell Mobilization in Humans. 169
The molecular signature of impaired diabetic wound healing identifies serpinB3 as a healing biomarker. 169
A perspective on sirtuins in the metabolic syndrome. 168
Rosuvastatin stimulates clonogenic potential and anti-inflammatory properties of endothelial progenitor cells 166
Defective recruitment, survival and proliferation of bone marrow-derived progenitor cells at sites of delayed diabetic wound healing in mice 164
Number and function of endothelial progenitor cells as a marker of severity of diabetic vasculopathy. 164
Pharmacologic targeting of endothelial progenitor cells. 162
NAD+-dependent SIRT1 deactivation has a key role on ischemia-reperfusion-induced apoptosis. 161
Estrogen receptor functions and pathways at the vascular immune interface 161
Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism. 160
Endothelial progenitor cells in diabetes mellitus. 159
The dipeptidyl peptidase-4 inhibitor Saxagliptin improves function of circulating pro-angiogenic cells from type 2 diabetic patients. 156
The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha. 155
Inhibition of the Fission Machinery Mitigates OPA1 Impairment in Adult Skeletal Muscles 155
Angiogenic Abnormalities in Diabetes Mellitus: Mechanistic and Clinical Aspects 155
Improved function of circulating angiogenic cells is evident in type 1 diabetic islet-transplanted patients. 154
The Redox Enzyme p66Shc Contributes to Diabetes and Ischemia-Induced Delay in Cutaneous Wound Healing 153
Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens. 153
Stem cell compartmentalization in diabetes and high cardiovascular risk reveals the role of DPP-4 in diabetic stem cell mobilopathy. 152
Pharmacologic PPAR-γ Activation Reprograms Bone Marrow Macrophages and Partially Rescues HSPC Mobilization in Human and Murine Diabetes 152
Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: A randomized placebo-controlled trial 151
Myeloid calcifying cells promote atherosclerotic calcification via paracrine activity and allograft inflammatory factor-1 overexpression 151
Diabetes modifies the relationships among carotid plaque calcification, composition and inflammation 151
Endothelial progenitor cells are reduced in acromegalic patients and can be restored by treatment with somatostatin analogs 147
Concise Review: Perspectives and Clinical Implications of Bone Marrow and Circulating Stem Cell Defects in Diabetes 144
Diabetes mellitus impairs circulating proangiogenic granulocytes 144
Effects of androgens on endothelial progenitor cells in vitro and in vivo 143
Effects of SGLT2 inhibitors on circulating stem and progenitor cells in patients with type 2 diabetes 143
Direct effects of DPP-4 inhibition on the vasculature. Reconciling basic evidence with lack of clinical evidence 142
Technical notes on endothelial progenitor cells: Ways to escape from the knowledge plateau 141
DPP-4 inhibition has no acute effect on BNP and its N-terminal pro-hormone measured by commercial immune-assays. A randomized cross-over trial in patients with type 2 diabetes 137
Fenofibrate increases circulating haematopoietic stem cells in people with diabetic retinopathy: a randomised, placebo-controlled trial 136
Muscle insulin sensitivity and glucose metabolism are controlled by the intrinsic muscle clock. 135
p66Shc gene expression in peripheral blood mononuclear cells and progression of diabetic complications 133
The peritoneum as a natural scaffold for vascular regeneration 129
Circulating Cellular Players in Vascular Calcification. 128
Leucocyte Abnormalities in Synovial Fluid of Degenerative and Inflammatory Arthropathies 127
Circulating smooth muscle progenitors and atherosclerosis. 126
Selective estrogen receptor-{alpha} agonist provides widespread heart and vascular protection with enhanced endothelial progenitor cell mobilization in the absence of uterotrophic action. 125
Sensory neuropathy hampers nociception-mediated bone marrow stem cell release in mice and patients with diabetes 124
Padi4-dependent NETosis enables diet-induced gut hyperpermeability, translating dysbiosis into systemic inflammation and dysmetabolism 121
Hypoglycemia affects the changes in endothelial progenitor cell levels during insulin therapy in type 2 diabetic patients. 121
Endothelial dysfunction in diabetes: the role of reparatory mechanisms. 120
Targeting SETD7 Rescues Diabetes-induced Impairment of Angiogenic Response by Transcriptional Repression of Semaphorin 3G 120
Post-transcriptional and epigenetic regulation of estrogen signaling 118
The increased dipeptidyl peptidase-4 activity is not counteracted by optimized glucose control in type 2 diabetes, but is lower in metformin-treated patients. 118
Putative circulating adipose tissue-derived stem cells, obesity, and metabolic syndrome features 112
Loss of hematopoietic cell-derived oncostatin M worsens diet-induced dysmetabolism in mice 108
CK2β Regulates Hematopoietic Stem Cell Biology and Erythropoiesis 106
Strategies for Enhancing Progenitor Cell Mobilization and Function in Diabetes. 106
Restoring stem cell mobilization to promote vascular repair in diabetes. 105
Widespread increase in myeloid calcifying cells contributes to ectopic vascular calcification in type 2 diabetes. 103
Pharmacologic targeting of the diabetic stem cell mobilopathy 101
Diabetes pharmacotherapy and circulating stem/progenitor cells. State of the art and evidence gaps 101
The BET Protein Inhibitor Apabetalone Rescues Diabetes-induced Impairment of Angiogenic Response by Epigenetic Regulation of Thrombospondin-1 98
Hematopoietic stem cells and metabolic deterioration in Alström syndrome, a rare genetic model of the metabolic syndrome 97
Deletion of the redox enzyme p66shc promotes diabetic wound healing in mice 93
Semisolid Wet Sol–Gel Silica/Hydroxypropyl Methyl Cellulose Formulation for Slow Release of Serpin B3 Promotes Wound Healing In Vivo 92
Synovial Fluid from Patients with Osteoarthritis Shows Different Inflammatory Features Depending on the Presence of Calcium Pyrophosphate Crystals 91
Evaluation of post-natal angiogenesis in a mouse hind limb ischemia model 84
The role of p66Shc knockout in a murine model of diabetic ulcers and peripheral ischemia 79
Mannose Receptor Deficiency Impacts Bone Marrow and Circulating Immune Cells during High Fat Diet Induced Obesity 77
Exploring neutrophils as therapeutic targets in cardiometabolic diseases 70
The role of p66Shc in the development of obesity and metabolic disorders: a translational study 48
Oncostatin M is dispensable for the regulation of hematopoietic stem/progenitor cell traffic by neutrophils 29
The contribution of circulating cells to atherosclerotic plaque calcification 3
Totale 14.802
Categoria #
all - tutte 47.046
article - articoli 46.633
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.679


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.130 0 0 0 0 71 89 38 113 182 281 202 154
2021/20221.329 33 121 199 109 102 81 60 157 67 29 107 264
2022/20231.016 181 130 20 172 115 123 14 61 124 20 44 12
2023/2024554 24 92 66 43 25 60 24 27 20 66 54 53
2024/20252.272 4 127 119 95 245 87 155 198 179 126 382 555
2025/20264.738 501 669 1.299 1.753 516 0 0 0 0 0 0 0
Totale 14.802